Skip to content
healthcare.dev

Nicotine Mini

NDC 59726-262, nicotine polacrilex, lozenge, from P & L Development, LLC.

Product NDC
59726-262
Status
Listed
Labeler
P & L Development, LLC
Dosage form
LOZENGE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA207868
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59726-262 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NICOTINE2 mg/1

Pharmacologic classes

Cholinergic Nicotinic Agonist [EPC]; Nicotine [CS]

Package NDCNDC-11Package
59726-262-27597260262271 BOTTLE, PLASTIC in 1 BOX (59726-262-27) / 27 LOZENGE in 1 BOTTLE, PLASTIC
59726-262-35597260262355 BOTTLE, PLASTIC in 1 BOX (59726-262-35) / 27 LOZENGE in 1 BOTTLE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 59726-262 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59726-262 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59726-262. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.